These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 4369870

  • 1. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW, Mülders MS, Van Rensburg JJ.
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract] [Full Text] [Related]

  • 2. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF, Lee CL, Atassi MZ.
    Biochim Biophys Acta; 1973 Oct 18; 322(2):245-50. PubMed ID: 4358084
    [No Abstract] [Full Text] [Related]

  • 3. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R, Wadström T.
    Biochim Biophys Acta; 1973 Oct 10; 321(2):569-84. PubMed ID: 4357667
    [No Abstract] [Full Text] [Related]

  • 4. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW, Mülders MS, Van Rensburg JJ.
    Onderstepoort J Vet Res; 1973 Dec 10; 40(4):151-4. PubMed ID: 4369993
    [No Abstract] [Full Text] [Related]

  • 5. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A, Ionesco H.
    Ann Microbiol (Paris); 1975 Dec 10; 126(3):343-56. PubMed ID: 174471
    [Abstract] [Full Text] [Related]

  • 6. Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Bird RA, Low MG, Stephen J.
    FEBS Lett; 1974 Aug 30; 44(3):279-81. PubMed ID: 4370089
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW, Mülders MS.
    Onderstepoort J Vet Res; 1975 Sep 30; 42(3):91-8. PubMed ID: 172828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two molecular forms of Clostridium perfringens alpha-toxin associated with lethal, hemolytic and enzymatic activities.
    Sugahara T, Osaka A.
    Jpn J Med Sci Biol; 1970 Feb 30; 23(1):61-6. PubMed ID: 4317541
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proteases of Clostridium botulinum. 3. Isolation and characterization of proteases from Clostridium botulinum types A,B,C,D and F.
    Tjaberg TB.
    Acta Vet Scand; 1973 Feb 30; 14(4):538-59. PubMed ID: 4585531
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.